Ma waho aʻe o nā ʻupena makika: No ke aha he koʻikoʻi ka hoʻāʻo ʻana ma hope o ka pale ʻana i ka 2025 Arbovirus outbreak
Geneva, ʻAukake 6, 2025- E like me ka World Health Organization (WHO) e ao aku nei i ka hoʻokē ʻai ʻana o ka chikungunya ma nā ʻāina he 119, ke hoʻoikaika nei ka poʻe loea olakino i kahi ākea koʻikoʻi i ka pale ʻana i nā maʻi i lawe ʻia e ka namu: ʻoiai me nā hana pale ikaika, pono mau ka hoʻāʻo ʻana ma hope o ka hōʻike. Hōʻike ʻo Testsealabs, kahi mea hāʻawi hoʻoponopono diagnostics koʻikoʻi i kāna mau pahu hoʻāʻo wikiwiki ma ke ʻano he mea hana koʻikoʻi i ka hakakā ʻana i nā mea hoʻoweliweli o ka chikungunya, dengue, a me Zika virus.
ʻO ka maʻi maʻi huna: piʻi aʻe nā hihia me ka hoʻoikaika ʻana
Ua ʻike ʻo 2025 i ka hana arbovirus i ʻike ʻole ʻia ma ka honua holoʻokoʻa. Ua hōʻike ʻo ʻAmelika ma luna o 7 miliona mau maʻi dengue ma ʻApelila wale nō - he 52% ka piʻi ʻana mai ka huina makahiki o 2023 (WHO, 2024). I kēia manawa, ua loaʻa i ka chikungunya ka poʻe 220,000 ma waena o 14 mau ʻāina i ka hapa mua o 2025, me Farani a me Italia e kākau ana i kā lākou hoʻouna mua ʻana mai ka makahiki 2019 (ECDC, 2025).
"Ke manaʻo wahaheʻe nei ka poʻe i ka ʻupena makika a me nā mea hoʻopau i ka pale piha," wahi a Kauka Elena Rodriguez, ka loea maʻi maʻi ma ka Tropical Medicine Institute. "Ke hōʻike nei kā mākou noiʻi ʻana he 85% o nā hale e hoʻohana i nā ala kūpono ʻole e like me ka ultrasonic repellers, ʻoiai ʻo 60% o nā huakaʻi hōʻailona e hoʻopaneʻe i ka hoʻāʻo ʻana ma mua o ka puka makani koʻikoʻi."
ʻO ka Luʻi Diagnostic: Ke Lapaʻa nā hōʻailona
ʻO ka like ʻana o ka maʻi ma waena o nā arboviruses e hana i nā lohi weliweli i ka mālama ʻana. He noiʻi ʻo Honduran i paʻi ʻia maʻO PLOS i mālama ʻole ʻia i nā maʻi TropicalUa loaʻa i nā kauka mālama mua i ʻike pololei i ka 30.8% o nā hihia arbovirus, me nā helu hōʻoia dengue ma lalo o 8.23%.
"ʻO ka 'breakbone fever' o Chikungunya he 80% o nā hōʻailona me ka dengue, me ke kuni kiʻekiʻe a me ka ʻeha hui," wehewehe ʻo Kauka Rodriguez. "Me ka ʻole o ka hoʻāʻo ʻana, ʻaʻole hiki i nā kauka loea ke hoʻokaʻawale i kēia mau maʻi - a hoʻonui ka misdiagnosis i nā pilikia hoʻopiʻi koʻikoʻi e 3.2 mau manawa."
Nā Hoʻonā Testsealabs: Mālamalama i loko o 15 mau minuke
Hoʻopuka ʻo Testsealabs 'arbovirus hoʻāʻo portfolio i kēia pono koʻikoʻi me ka CE-certified, ISO 13485-compliant rapid diagnostic kits i hoʻolālā ʻia no ka ʻoihana a me ka hoʻohana home.
| Inoa Huahana | Nā Huhu ʻIke | pukaaniani hoao ana | Ka manawa huli | Nā palapala hōʻoia |
| Ho'āʻo Chikungunya IgM | ʻO Chikungunya virus-specific IgM antibodies | 5-12 mau lā ma hope o nā hōʻailona | 15 minuke | CE, ISO 13485 |
| Ho'āʻo Dengue IgG/IgM | ʻO ka maʻi Dengue IgG/IgM antibodies | 7+ mau lā ma hope o nā hōʻailona | 15 minuke | CE, ISO 13485 |
| Ho'āʻo Combo | Dengue NS1 antigen + Dengue IgG/IgM + Zika/Chikungunya IgG/IgM | Acute a convalescent phase | 15 minuke | CE, ISO 13485 |
Hāʻawi ka Combo Test i ka hōʻike ʻokoʻa like ʻole o nā maʻi co-circulating - kahi hiki i manaʻo ʻia he "pono" i ka WHO's 2024 Global Arbovirus Strategy. ʻO kāna hoʻolālā ʻaʻohe mea pono e ʻae i nā hopena i loko o 15 mau minuke me ka hoʻohana ʻana i ke koko holoʻokoʻa a i ʻole serum.
Ola honua i kou mau lima
I ka hoʻonui ʻana o ka hoʻololi ʻana i ka namu Aedes, lilo ka hoʻāʻo ʻana iā ia iho i mea pale mua, ua hōʻike kā mākou mau pahu i ka 97.3% ʻaelike me nā hualoaʻa hōʻike i nā hoʻokolohua lapaʻau ma waena o 12 mau ʻāina endemic.
Loaʻa nā huahana Testsealabs ma o nā mea hoʻolaha koho a me nā kahua pūnaewele. No nā keʻena mālama ola kino, ʻo nā koho kauoha nui e komo pū me ka hoʻouna ʻana i nā kaulahao anu a me nā mea hoʻomaʻamaʻa piha.
No Testsealabs
Hoʻokumu ʻia i ka makahiki 2015, ʻo Hangzhou Testsea Biotechnology ka mea kūikawā i nā hoʻonā diagnostic wikiwiki no nā maʻi maʻi.
Hoʻokuʻu: Aia i kēia hoʻolaha paʻi nā ʻōlelo e nānā i mua. Hiki ke ʻokoʻa nā hopena maoli. No ka hoʻohana diagnostic in vitro wale nō nā huahana Testsealabs. E nīnau mau i nā ʻoihana mālama ola no ka ʻōlelo aʻo.
Ka manawa hoʻouna: ʻAukake-06-2025



